Skip to main navigation menu Skip to main content Skip to site footer

Technical comment

Vol. 141 No. 4748 (2011)

Letter to the editor

  • P Sesma
  • E Ameneiros-Lago
Cite this as:
Swiss Med Wkly. 2011;141:w13302


  1. Kesten F, Aschwanden M, Gubser P, Glatz K, Daikeler T, Hess C. Giant cell arteritis. Swiss Med Wkly. 2011;141:w13272
  2. Weyand CM, Younge BR, Goronzy JJ. IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis. Curr Opin Rheumatol. 2011;23(1):43–9.
  3. Moller DR, Wysocka M, Greenlee BM, Ma X, Wahl L, Trinchieri G, et al. Inhibition of human interleukin-12 production by pentoxifylline. Immunology. 1997;91(2):197–203.
  4. Samardzic T, Jankovic V, Stosic-Grujicic S, Popadic D, Trajkovic V. Pentoxifylline inhibits the synthesis and IFN-gamma-inducing activity of IL-18. Clin Exp Immunol. 2001;124(2):274–81.
  5. Dukas LC, Schacht E, Mazor Z, Stähelin HB. A new significant and independent risk factor for falls in elderly men and women: a low creatinine clearance of less than 65 ml/min. Osteoporos Int. 2005;16(3):332–8.
  6. Schacht E. Osteoporosis in rheumatoid arthritis – significance of alfacalcidol in prevention and therapy. Z Rheumatol. 2000;59(Suppl 1):10–20.
  7. Zold E, Szodoray P, Nakken B, Barath S, Kappelmayer J, Csathy L, et al. Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease. Autoimmun Rev. 2011;10(3):155–62.
  8. Fernández-Fernández FJ. Might pentoxifylline have a role as adjuvant therapy for patients with giant cell arteritis? Drugs Aging. 2011;28(19):847.
  9. Brack A, Rittner HL, Younge BR, Kaltschmidt C, Weyand CM, Goronzy JJ. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras. J Clin Invest. 1997;99(12):2842–50.
  10. Mazlumzadeh M, Hunder GG, Easley KA, Calamia KT, Matteson EL, Griffing WL, et al. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum. 2006;54(10):3310–8.